Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planTo cover taxesOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 5 of the 13 calendar months from Oct 2025 to Oct 2026: Nov 2025, Jan 2026, Feb 2026, Mar 2026 and May 2026.
- Largest single sale: $3.2M (162,820 shares) of Adaptive Biotechnologies Corp on Nov 28, 2025. Filing
- Last sale before this period: May 16, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | Chief Financial Officer | Nov 3, 2021 | May 20, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- May 18, 2026, Adaptive Biotechnologies Corp: sold 3,115 shares for $41K, to cover taxes. 1 filing: 1
- Mar 11, 2026, Adaptive Biotechnologies Corp: sold 18,672 shares for $246K, to cover taxes. 1 filing: 1
- Mar 4, 2026, Adaptive Biotechnologies Corp: 61,875 shares awarded. 1 filing: 1
- Feb 4, 2026, Adaptive Biotechnologies Corp: sold 2,145 shares for $40K, under a disclosed plan; 2,145 shares acquired by exercising options. 1 filing: 1
- Jan 12, 2026, Adaptive Biotechnologies Corp: sold 4,290 shares for $77K, under a disclosed plan; 4,290 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.